Tadeu Marroco
Management
Good morning, everyone. I'm delighted to welcome you to our 2024 Preliminary Results Presentation. With me this morning is Soraya Benchikh, CFO and Victoria Buxton, Group Head of Investors Relations. I will begin with our transformation highlights and the progress we have made during our investment year. Soraya will then take you through our financial results in more detail before I return to talk more about our performance outlook ahead of Q&A. With that, I would like to draw your attention to the disclaimers on Slide 2 and 3. Let's begin by looking at the positive transformation momentum we are driving, starting with some highlights. 2024 was a key moment in our transformation journey as we sharpened our execution, enabling us to navigate near-term market challenges and deliver an improved performance in the second half. We have delivered group results in line with expectations, which Soraya will talk about in more detail. Smokeless accounts for 17.5% of group revenue, up 1 percentage point versus last year. We added 3.6 million smokeless consumers, reaching 29.1 million, mainly driven by our continued success in Modern Oral. Our focus on quality growth, balancing top and bottom line delivery, has driven a further improvement in new category contribution, up GBP251 million and a 7 percentage point increase in our category contribution margin on an organic constant rates basis. We are committed to rewarding shareholders with strong cash returns, and I'm pleased with our progress improving financial flexibility. Enabling the initiation of sustainable share buyback, continued progress on the leverage to within our target range at 2.4 times, alongside our progressive dividend with 2% growth announced today. Our foundations are solid, and I'm confident that the choices we have made and the actions we have taken through our investment year are the right way forward for BAT. I have been clear that we needed to invest to strengthen our U.S. business, accelerate innovation momentum, and enhance capabilities that support our strategic delivery. While there is more to do, we are making clear progress. Our previously announced commercial plans in the U.S. are completed, and I'm encouraged that our performance accelerated in the second half. Through our improved innovation ecosystem, our new category growth accelerated in the second half, driven by Glo, Hyper Pro, and our refreshed Velo Mix in the U.S. Furthermore, we are excited about the Q4 launchings of our latest innovations, including Velo Plus. As previously highlighted, we do not expect the journey ahead to be linear. We will share more detail on the key drivers and assumptions behind our 2025 guidance later in the presentation. We remain committed to returning to 3% to 5% revenue and 4% to 6% APFO growth adjusted for Canada at constant rates in 2026. And with that, I will hand over to Soraya to take you through our results in more detail.